J06BD Antiviral monoclonal antibodies Antiviral monoclonal antibodies Antiviral monoclonal antibodies Antiviral monoclonal antibodies L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
8 active ingredients 8 principios activos 8 个活性成分 8 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Nirsevimab
J06BD08active US GB CA SG CN · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA SG CN ES MX TW EU · unknown AU HK - Palivizumab
J06BD01active GB SG TW EU · and 6 more y 6 más 另有 6 个 另有 6 個
active GB SG TW EU · discontinued CA ES · unknown AU HK - Clesrovimab
J06BD10active US GB CA SG ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA SG ES MX EU · unknown AU - Casirivimab
J06BD07active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · withdrawn CA ES EU - Sipavibart
J06BD09active CA EU · and 4 more y 4 más 另有 4 个 另有 4 個
active CA EU · discontinued ES · unknown AU - Sotrovimab
J06BD05active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · withdrawn CA ES EU - Tixagevimab
J06BD03active GB · and 5 more y 5 más 另有 5 个 另有 5 個
active GB · discontinued CA · withdrawn ES EU - Ansuvimab
J06BD04active US
active US
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).